The purpose of this phase III, open-label study is to determine the safety and tolerability
of cyclosporine in the treatment of dry eye syndrome.
- Diagnosis of dry eye syndrome
- Intraocular or refractive surgery in the study eye within 3 months prior to study
- Unwilling to discontinue use of contact lenses during the study
- Pregnancy or lactation